Liraglutide-d8 tetraTFA is a deuterium-labeled version of Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, intended for the study of type 2 diabetes mellitus. Stable heavy isotopes, like deuterium, are incorporated into drug molecules primarily for quantitation during drug development processes, with the potential to influence the pharmacokinetic and metabolic profiles of drugs.
- Can be utilized as a tracer.
- Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.